SENS

+ Watchlist + Portfolio

Senseonics Holdings, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $9.11
52-Week Range: $4.79 – $11.58
Market Cap: $466.35M
P/E (TTM): —
EPS (TTM): -2.24
Dividend Yield: —

Advanced Metrics

Price/Book: 5.16
PEG Ratio: —
Return on Equity: -118.24%
Return on Assets: -41.41%
Gross Margin: 54.87%
Operating Margin: -248.48%
Profit Margin: -225.34%
Current Ratio: 6.75
Debt/Equity: 0.70
Total Debt: $62.82M
Free Cash Flow: $-59.24M
Revenue Growth: 117.80%
Earnings Growth: —
Enterprise Value: $401.84M

SENS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$16.39M	$22.39M	$22.47M	$35.26M
Cost of Revenue	$13.66M	$19.30M	$21.94M	$19.49M
Gross Profit	$2.73M	$3.09M	$533.00K	$15.76M
Research & Development	$39.72M	$48.75M	$41.14M	$31.59M
Selling, General & Admin	$31.63M	$29.94M	$34.23M	$52.51M
Operating Expenses	$71.35M	$78.69M	$75.38M	$84.10M
Operating Income	-$68.63M	-$75.60M	-$74.84M	-$68.34M
EBITDA	$161.81M	-$48.01M	-$68.70M	-$62.65M
Pretax Income	$142.12M	-$60.39M	-$78.62M	-$69.11M
Net Income	$142.12M	-$60.39M	-$78.62M	-$69.11M
Diluted EPS	-0.11	-0.11	-2.50	-1.66
Diluted Shares	618.21M	567.97M	629.72M	41.73M

SENS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$35.79M	$75.71M	$74.60M	$40.23M
Receivables	$2.79M	$6.60M	$8.08M	$12.43M
Inventory	$7.31M	$8.78M	$4.42M	$6.70M
Current Assets	$161.20M	$130.03M	$91.44M	$117.53M
Total Assets	$177.67M	$138.22M	$100.44M	$126.27M
Current Liabilities	$31.47M	$17.26M	$38.85M	$24.35M
Long-Term Debt	$56.38M	$41.20M	$34.70M	$35.59M
Total Debt	$75.38M	$47.78M	$61.05M	$41.37M
Total Liabilities	$180.25M	$102.42M	$116.99M	$65.22M
Retained Earnings	-$808.87M	-$869.26M	-$947.87M	-$1.02B
Shareholders' Equity	-$2.58M	$35.80M	-$16.55M	$61.05M
Working Capital	$129.73M	$112.77M	$52.59M	$93.19M
Net Debt	$36.17M	—	—	—

SENS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$66.31M	-$70.16M	-$60.47M	-$59.13M
Capital Expenditure	-$312.00K	-$350.00K	-$2.24M	-$1.12M
Free Cash Flow	-$66.62M	-$70.51M	-$62.70M	-$60.24M
Depreciation & Amortisation	$985.00K	$1.28M	$1.48M	$1.51M
Stock-Based Compensation	$8.62M	$8.67M	$9.22M	$10.15M
Investing Cash Flow	$26.88M	$89.71M	$32.84M	-$53.42M
Financing Cash Flow	$41.76M	$20.37M	$26.83M	$78.19M
Net Change in Cash	$2.33M	$39.92M	-$797.00K	-$34.36M

SENS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$6.26M	$6.65M	$8.10M	$14.26M	$11.71M
Cost of Revenue	$4.75M	$3.53M	$4.63M	$6.59M	$4.77M
Gross Profit	$1.50M	$3.12M	$3.47M	$7.67M	$6.94M
Research & Development	$7.30M	$7.71M	$7.76M	$8.82M	$8.61M
Selling, General & Admin	$7.69M	$9.73M	$15.31M	$19.77M	$30.18M
Operating Expenses	$14.99M	$17.44M	$23.07M	$28.59M	$38.79M
Operating Income	-$13.49M	-$14.32M	-$19.60M	-$20.93M	-$31.85M
EBITDA	-$12.45M	-$12.99M	-$17.98M	-$19.23M	-$30.60M
Pretax Income	-$14.26M	-$14.50M	-$19.53M	-$20.82M	-$32.33M
Net Income	-$14.26M	-$14.50M	-$19.53M	-$20.82M	-$32.33M
Diluted EPS	-0.02	-0.02	-0.43	—	-0.71
Diluted Shares	718.88M	813.36M	44.95M	—	45.82M

SENS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$39.31M	$31.52M	$34.46M	$40.23M	$29.61M
Receivables	$6.32M	$7.23M	$9.37M	$12.43M	$15.05M
Inventory	$4.51M	$4.71M	$6.32M	$6.70M	$8.31M
Current Assets	$78.37M	$141.59M	$131.28M	$117.53M	$92.28M
Total Assets	$87.21M	$150.27M	$139.92M	$126.27M	$102.86M
Current Liabilities	$11.38M	$14.78M	$21.07M	$24.35M	$26.32M
Long-Term Debt	$34.96M	$35.23M	$35.27M	$35.59M	$35.91M
Total Debt	$41.08M	$41.24M	$41.16M	$41.37M	$43.14M
Total Liabilities	$52.01M	$55.55M	$61.76M	$65.22M	$68.52M
Retained Earnings	-$962.13M	-$976.63M	-$996.16M	-$1.02B	-$1.05B
Shareholders' Equity	$35.20M	$94.72M	$78.17M	$61.05M	$34.34M
Working Capital	$66.99M	$126.81M	$110.20M	$93.19M	$65.96M
Net Debt	—	$3.71M	$808.00K	—	$6.30M

SENS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$16.08M	-$9.27M	-$15.82M	-$17.96M	-$32.02M
Capital Expenditure	-$434.00K	-$124.00K	-$164.00K	-$394.00K	-$111.00K
Free Cash Flow	-$16.51M	-$9.39M	-$15.98M	-$18.36M	-$32.14M
Depreciation & Amortisation	$384.00K	$370.00K	$376.00K	$382.00K	$545.00K
Stock-Based Compensation	$1.84M	$2.89M	$2.79M	$2.63M	$2.28M
Investing Cash Flow	-$25.32M	-$69.63M	$18.89M	$22.64M	$18.00M
Financing Cash Flow	$6.12M	$71.11M	-$134.00K	$1.10M	$3.41M
Net Change in Cash	-$35.29M	-$7.79M	$2.94M	$5.78M	-$10.62M

Market Snapshot

About

Senseonics Holdings, Inc. is a medical technology company focused on developing and commercializing continuous glucose monitoring systems for people with diabetes. The company produces the Eversense implantable CGM system, which provides long-term glucose monitoring through a small sensor placed under the skin. Senseonics aims to improve diabetes management through innovative sensor technology.